The unfolding COVID-19 pandemic has seen an unprecedented sharing of information to support clinicians in making clinical decisions at the coal-face.  But has this pressure to publish data come at the cost of lower standards of governance?

Colin McArthur, co-lead of the ANZ arm of the REMAP-CAP study joins Todd on the podcast to discuss the trials and tribulations of hydroxychloroquine, and THAT observational study.

<p>The unfolding COVID-19 pandemic has seen an unprecedented sharing of information to support clinicians in making clinical decisions at the coal-face. &nbsp;But has this pressure to publish data come at the cost of lower standards of governance?</p>
<p>Colin McArthur, co-lead of the ANZ arm of the REMAP-CAP study joins Todd on the podcast to discuss the trials and tribulations of hydroxychloroquine, and THAT observational study.</p>

This podcast is dedicated to the hard-working doctors, nurses and allied health professionals striving for excellence

Osler Podcasts

This podcast is dedicated to the hard working doctors, nurses and allied health professionals who are continually striving for excellence in critical care.

Advertisement